Zaluvida has boosted the series A round raised by Targedys, which is working on products to regulate the appetite, to a total of $11.1m over the past year.

France-based food technology developer Targedys has raised €3.5m from life sciences company Zaluvida to extend its series A round to €10.4m ($11.1m).

The investment follows a €5.8m initial tranche secured from venture capital firms Seventure Partners and Pontifax, and NCI, a public-private partnership focused on the Normandy region, in April 2016. Bpifrance, France’s public investment bank, added €1.1m in non-dilutive funding in March this year.

Targedys is developing two products – ProbioSatys and ProbioNutrys – to regulate the appetite, targeting…